Securing Europe’s Antibiotic Supply: A More Functional Future
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
False
Advertisement
Small Molecules
Texas Takes on Tylenol
October 31, 2025
Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.
2 min read
Summarizing the Big Events in the Small Molecules Field
October 30, 2025
October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.
4 min read
MDIs and the Need for Greener Propellants
By Stephanie Vine, Julian Upton
October 27, 2025
Regulations are pushing companies to more environmentally friendly propellants, but how should capacity be scaled up?
5 min read
Reimagining LSD to Treat Mental Health Disorders
By Stephanie Vine
October 24, 2025
We speak with a biotech CEO about the potential of psychedelic medicine – and the challenges of working with stigmatized substances.
11 min read
Small Molecules
Business & Trends
Drug Delivery
Development & Clinical
Formulation
Facilities & Equipment
Insights into the GLP-1 Landscape
By Stephanie Vine
October 20, 2025
From compounding to new opportunities, we look at some of the insights shared at an AAPS workshop
11 min read
Inside the GLP-1 Phenomenon
October 15, 2025
With remarkable successes come inevitable hurdles. Find out what experts had to say about GLP-1 drug development during an AAPS workshop.
8 min read
Nominations Open for The Medicine Maker’s 2026 Power List
October 10, 2025
Nominate your drug development and healthcare heroes for our annual celebration!
1 min read
Green Propellants and the Future of Metered Dose Inhalers
By Andy Burns
October 9, 2025
The pressure is on to reduce the carbon footprint of respiratory drugs by using next-generation green propellants
3 min read
The Golden Age of Drug Discovery
By Stephanie Vine
October 6, 2025
Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.
7 min read
